Skip to main content

REVIEW article

Front. Bioeng. Biotechnol.

Sec. Organoids and Organ-On-A-Chip

Volume 13 - 2025 | doi: 10.3389/fbioe.2025.1515340

This article is part of the Research Topic Insights In Organoids and Organ-On-A-Chip 2024: Novel Developments, Current Challenges and Future Perspectives View all 6 articles

Organoids-on-a-Chip: Microfluidic Technology Enables Culture of Organoids with Enhanced Tissue Function and Potential for Disease Modeling

Provisionally accepted
  • 1 Department of Surgery, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
  • 2 Department of Internal Medicine, Erasmus MC Transplant Institute, University Medical Center Rotterdam,, Rotterdam, Netherlands
  • 3 Applied Stem Cell Technologies, Department of Bioengineering Technologies, University of Twente, Enschede, Netherlands
  • 4 BIOS Lab on a Chip Group, MESA+ Institute, Technical Medical Center, Max Planck Institute for Complex Fluid Dynamics, University of Twente, Enschede, Netherlands

The final, formatted version of the article will be published soon.

    Organoids are stem-cell derived tissue structures mimicking specific structural and functional characteristics of human organs. Despite significant advancements in the field over the last decade, challenges like limited long-term functional culture and lack of maturation are hampering the implementation of organoids in biomedical research. Culture of organoids in microfluidic chips is being used to tackle these challenges through dynamic and precise control over the organoid microenvironment. This review highlights the significant breakthroughs that have been made in the innovative field of 'organoids-on-chip', demonstrating how these have contributed to advancing organoid models. We focus on the incorporation of organoids representative for various tissues into chips and discuss the latest findings in multi-organoids-on-chip approaches. Additionally, we examine current limitations and challenges of the field towards the development of reproducible organoids-on-chip systems. Finally, we discuss the potential of organoids-on-chip technology for both in vitro and in vivo applications.

    Keywords: Organoid, organ-on-a-chip, Tissue Engineering, Biofabrication, drug screening, personalized medicine

    Received: 22 Oct 2024; Accepted: 12 Feb 2025.

    Copyright: © 2025 Papamichail, Koch, Veerman, Broersen and Van Der Meer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Lena Sophie Koch, Applied Stem Cell Technologies, Department of Bioengineering Technologies, University of Twente, Enschede, Netherlands
    Andries Van Der Meer, Applied Stem Cell Technologies, Department of Bioengineering Technologies, University of Twente, Enschede, Netherlands

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more